BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9598451)

  • 21. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
    Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
    Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
    Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
    Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
    Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
    Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
    Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
    Win K; Thwe Y; Lwin TT; Win K
    Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria.
    Metzger W; Mordmüller B; Graninger W; Bienzle U; Kremsner PG
    J Antimicrob Chemother; 1995 Oct; 36(4):723-8. PubMed ID: 8591949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
    Na Bangchang K; Karbwang J; Banmairuroi V; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):221-5. PubMed ID: 8266221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
    Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
    Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
    Salako LA; Adio RA; Walker O; Sowunmi A; Stürchler D; Mittelholzer ML; Reber-Liske R; Dickschat U
    Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mefloquine-resistant falciparum malaria on the Thai-Burmese border.
    Nosten F; ter Kuile F; Chongsuphajaisiddhi T; Luxemburger C; Webster HK; Edstein M; Phaipun L; Thew KL; White NJ
    Lancet; 1991 May; 337(8750):1140-3. PubMed ID: 1674024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.
    Obonyo CO; Ochieng F; Taylor WR; Ochola SA; Mugitu K; Olliaro P; ter Kuile F; Oloo AJ
    Trans R Soc Trop Med Hyg; 2003; 97(5):585-91. PubMed ID: 15307433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose artemisinin-mefloquine treatment for acute uncomplicated falciparum malaria.
    Tran TH; Arnold K; Nguyen TH; Pham PL; Nguyen TD; Bui MC; Le MT; Mach QP; Le HV; Pham PM
    Trans R Soc Trop Med Hyg; 1994; 88(6):688-91. PubMed ID: 7886773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
    Poirot E; Vittinghoff E; Ishengoma D; Alifrangis M; Carneiro I; Hashim R; Baraka V; Mosha J; Gesase S; Chandramohan D; Gosling R
    PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
    Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ
    Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata.
    Basu A; Saha S; Guha SK
    J Assoc Physicians India; 2015 May; 63(5):32-7. PubMed ID: 26591142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
    Staedke SG; Kamya MR; Dorsey G; Gasasira A; Ndeezi G; Charlebois ED; Rosenthal PJ
    Lancet; 2001 Aug; 358(9279):368-74. PubMed ID: 11502317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma.
    Tin F; Nyunt Hlaing ; Lim MA; Win S; Lasserre R
    Trans R Soc Trop Med Hyg; 1987; 81(6):910-2. PubMed ID: 3332509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.